Johnson & Johnson
JNJ
|
News
|
$146.315
0.4%
1.3M
|
Health Technology
(0.0% 1d) (-6.8% 1m) (-11.4% 1y) (0.0% 2d) (0.1% 3d) (-2.2% 7d) (NaN% volume)
Earnings Calendar: 2024-01-23
Market Cap: $ 352,587,407,546
http://www.jnj.com
Sec Filling | Patents | 132200 employees
(US) Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
vaccine cardiovascular eye infectious disease diabetes diabetic hypertension urea pulmonary hypertension women health immunology metabolic women
add to watch list Paper trade email alert is off
Press-releases
White River Bancshares Co. Earns $509,000, or $0.51 Per Diluted Share, in First Quarter 2024; Highlighted by Higher Net Interest Income and Double Digit Loan and Deposit Growth Year-Over-Year
Published: 2024-04-19 (Crawled : 13:00) - globenewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
first growth
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
RPRX | $27.93 0.14% 300K
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
first pharma royalty financial results
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
fda for car-t
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
companies biopharma platform
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
miss
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectati...
Published: 2024-04-19 (Just crawled : 14:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
miss
Compass Diversified-Backed The Honey Pot Co. Strengthens Its Board With The Appointment of Three New Directors
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
CODI | News | $22.725 1.77% 21K
|
Finance
|
| O: 0.36%
H: 0.0%
C: 0.0%
pot honey
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $25.4 3.29% 1.5K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
companies biopharma platform
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
fda biosimilar approval for stelara
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-18 (Crawled : 18:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $25.4 3.29% 1.5K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
biopharma platform
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Last 48 Hours Insiders Buying
CLSD | $1.42 7.58% 100K
|
Health Technology
|
14:00
CDZI P 25000 | $2.32 3.11% 35K
|
Utilities
|
14:00
ETST P 39000 | $0.068 43K
|
Manufacturing
|
13:30
FNLC P 1275 | $22.47 1.4% 6.6K
|
Finance
|
12:30
ADMQ | $0.0532 480K
|
|
10:30
AXR P 2400 | $22.26 0.41% 110
|
Finance
|
21:00
QCRH P 118 | $56.39 1.77% 8.1K
|
Finance
|
18:01
VUZI P 7500 | $1.225 -2.78% 100K
|
Electronic Technology
|
18:00
RMCF | $3.5501 310
|
Consumer Non-Durables
|
20:10